As survival rates and tumor exclusion decreased in mice receiving immunized CD4+ and CD8+ cells, compared with those receiving immunized CD3+ cells, it was suggested that NKT cells, CD3+CD4−CD8−, might increase antitumor response induction by WEHI-NDV. This evidence concerns the gene CD8A and neoplasm.